Literature DB >> 20354416

Lessons from practice: risk of CIN 3 or cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21 to 24.

Gaea Moore1, Barbara Fetterman, J Thomas Cox, Nancy Poitras, Thomas Lorey, Walter Kinney, Philip E Castle.   

Abstract

OBJECTIVE: To characterize the risks of cervical intraepithelial neoplasia 3 (CIN 3) and cancer in women aged 21 to 24 with human papillomavirus (HPV)-positive atypical squamous cells of undetermined significance (ASC-US) and low-grade squamous intraepithelial lesion (LSIL) screening results in routine clinical practice.
MATERIALS AND METHODS: Quality assurance databases containing records of screening test and histologic findings from the Regional Laboratory of the Northern California Kaiser Permanente Medical Care Program were reviewed. Numbers of LSIL and HPV-positive ASC-US results and associated cancers and CIN 3 in women aged 21 to 24 during 2003 to 2007 were tabulated, and the corresponding risks were calculated overall and by year of age.
RESULTS: During the 5-year period from 2003 to 2007, 1,620 HPV-positive ASC-US and 2,175 LSIL were diagnosed in women aged 21 to 24, for which corresponding histologic finding is available. No invasive cancers were detected in association with LSIL and HPV-positive ASC-US screening results in this age group during this period. The risk of cancer was therefore 0% (95% CI = 0.00%-0.10%). The risk of CIN 3 associated with an HPV-positive ASC-US was 2.90% (95% CI = 2.14%-3.84%), with LSIL was 2.44% (95% CI = 1.83%-3.18%), and, for the 2 combined, the risk was 2.64% (95% CI = 2.15%-3.20%).
CONCLUSIONS: The risk of CIN 3 and cancer is low enough that management of women aged 21 to 24 with ASC-US and LSIL smears without immediate colposcopy should be considered, as is currently recommended for women aged 20 and younger.

Entities:  

Mesh:

Year:  2010        PMID: 20354416      PMCID: PMC2907060          DOI: 10.1097/LGT.0b013e3181b8b024

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  17 in total

1.  International incidence rates of invasive cervical cancer after introduction of cytological screening.

Authors:  L Gustafsson; J Pontén; M Zack; H O Adami
Journal:  Cancer Causes Control       Date:  1997-09       Impact factor: 2.506

2.  Regression of low-grade squamous intra-epithelial lesions in young women.

Authors:  Anna-Barbara Moscicki; Stephen Shiboski; Nancy K Hills; Kimberly J Powell; Naomi Jay; Evelyn N Hanson; Susanna Miller; K Lisa Canjura-Clayton; Sepidah Farhat; Jeanette M Broering; Teresa M Darragh
Journal:  Lancet       Date:  2004 Nov 6-12       Impact factor: 79.321

3.  Pregnancy outcome after cervical cone excision: a case-control study.

Authors:  Katrine Donvold Sjøborg; Ingvild Vistad; Siv S Myhr; Rune Svenningsen; Christine Herzog; Arild Kloster-Jensen; Gunhild Nygård; Sølvi Hole; Tom Tanbo
Journal:  Acta Obstet Gynecol Scand       Date:  2007       Impact factor: 3.636

4.  ACOG Practice Bulletin No. 99: management of abnormal cervical cytology and histology.

Authors: 
Journal:  Obstet Gynecol       Date:  2008-12       Impact factor: 7.661

5.  Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).

Authors:  Joan L Walker; Sophia S Wang; Mark Schiffman; Diane Solomon
Journal:  Am J Obstet Gynecol       Date:  2006-08       Impact factor: 8.661

6.  Risks for cervical intraepithelial neoplasia 3 among adolescents and young women with abnormal cytology.

Authors:  Anna-Barbara Moscicki; Yifei Ma; Charles Wibbelsman; Adaleen Powers; Teresa M Darragh; Sepideh Farhat; Ruth Shaber; Stephen Shiboski
Journal:  Obstet Gynecol       Date:  2008-12       Impact factor: 7.661

7.  Natural history of cervical squamous intraepithelial lesions: a meta-analysis.

Authors:  J Melnikow; J Nuovo; A R Willan; B K Chan; L P Howell
Journal:  Obstet Gynecol       Date:  1998-10       Impact factor: 7.661

Review 8.  Risk assessment to guide the prevention of cervical cancer.

Authors:  Philip E Castle; Mario Sideri; Jose Jeronimo; Diane Solomon; Mark Schiffman
Journal:  Am J Obstet Gynecol       Date:  2007-10       Impact factor: 8.661

Review 9.  2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests.

Authors:  Thomas C Wright; L Stewart Massad; Charles J Dunton; Mark Spitzer; Edward J Wilkinson; Diane Solomon
Journal:  Am J Obstet Gynecol       Date:  2007-10       Impact factor: 8.661

Review 10.  Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis.

Authors:  M Arbyn; M Kyrgiou; C Simoens; A O Raifu; G Koliopoulos; P Martin-Hirsch; W Prendiville; E Paraskevaidis
Journal:  BMJ       Date:  2008-09-18
View more
  5 in total

1.  Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years.

Authors:  Hormuzd A Katki; Mark Schiffman; Philip E Castle; Barbara Fetterman; Nancy E Poitras; Thomas Lorey; Li C Cheung; Tina Raine-Bennett; Julia C Gage; Walter K Kinney
Journal:  J Low Genit Tract Dis       Date:  2013-04       Impact factor: 1.925

2.  Atypical squamous cells of undetermined significance in patients with HPV positive DNA testing and correlation with disease progression by age group: an institutional experience.

Authors:  Erika F Rodriguez; Jordan P Reynolds; Sarah M Jenkins; Stephanie M Winter; Michael R Henry; Aziza Nassar
Journal:  Int J Clin Exp Pathol       Date:  2012-05-23

3.  Screening adolescents and young women.

Authors:  Lori A Boardman; Katina Robison
Journal:  Obstet Gynecol Clin North Am       Date:  2013-04-17       Impact factor: 2.844

4.  Intervention to improve follow-up for abnormal Papanicolaou tests: a randomized clinical trial.

Authors:  Carmen Radecki Breitkopf; Lauren Dawson; James J Grady; Daniel M Breitkopf; Carolyn Nelson-Becker; Russell R Snyder
Journal:  Health Psychol       Date:  2013-06-03       Impact factor: 4.267

Review 5.  New cervical cancer screening guidelines: was the annual pap too much of a good thing?

Authors:  Margaret M Fields
Journal:  J Adv Pract Oncol       Date:  2013-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.